Etiometry’s Automated Clinical Pathways Now Deployed Across All ICU Segments, Enabling Standardized Care and Cost Savings in the Most Complex and Expensive Units

Etiometry’s AI-based Clinical Intelligence Platform Delivers Significant Gains in ICU Care, Helping to Reduce Treatment Time and Improve Outcomes

Etiometry’s Automated Clinical Pathways Now Deployed Across All ICU Segments, Enabling Standardized Care and Cost Savings in the Most Complex and Expensive Units

Gina Foster
gfoster@etiometry.com

Etiometry, the pioneer and leader in AI-based clinical decision-support software for high-acuity units, continues to transform ICU care through its Clinical Pathway Automation, which enables care teams to standardize workflows in line with their hospital guidelines and thereby enhance patient outcomes and drive cost savings. In the third quarter of 2024, Etiometry accelerated deployment of Clinical Pathway Automation with pathways now present in all ICU segments (e.g., adult, cardiac, neuro, pediatric) – within top U.S. medical centers. Etiometry has plans to launch more pathways by the end of 2024 to address the growing demand and each unit type’s unique requirements.

“Reducing care variability has emerged as a key strategy for health systems to improve patient outcomes and resource efficiency – especially in high-acuity, high-stakes units,” said Shane Cooke, Etiometry CEO. “Etiometry tackles the complexities of standardizing care, helping hospitals maintain evidence-based protocols that reduce variation while at the same time empowering the care teams to make informed decisions using aggregated and visualized data on one screen.”

Clinical data show impressive results from Etiometry platform use, including a 22% reduction in time on mechanical ventilation¹ and an 18% reduction in vasoactive infusion time². These outcomes were driven by workflow automation that supports efficient escalation and safe de-escalation decisions made by the clinical team. The result is to help patients recover faster and reduce their exposure to live-saving, yet invasive treatments.

Since their introduction in 2021, Etiometry’s automated clinical pathways have continuously expanded in scope, including automated quality reporting, which launched last year. The deployed pathways, powered by Etiometry’s FDA-cleared risk algorithms, now include:

• ERT/SBT (Extubation Readiness Test / Spontaneous Breathing Trial)
• Vasoactive medication weaning
• Neuro-protective measures
• AKI (Acute Kidney Injury)
• Mechanical ventilation management
• Track and trigger for Resuscitation action plan
• GDT (Goal Directed Therapy)
• Norwood post operative management
• IVCO2 (Inadequate Ventilation of Carbon Dioxide) escalation of care
• Extubation guidelines pathway
• Fast track extubation pathway

Looking ahead, Etiometry plans to introduce new pathways for ARDS (Acute Respiratory Distress Syndrome), ventilator weaning, lung protective ventilation and cardiogenic shock, addressing growing demand for additional automated care pathways.

With its proven impact on ICU care, Etiometry’s Clinical Pathway Automation is setting a new benchmark for the future of critical care, enabling hospitals to deliver safer, more efficient, and consistently high-quality patient care.

Sources: 1. Borasino, S. et al. (2023) Automated Extubation Readiness Tool is Associated with Improved Outcomes Following Pediatric Cardiac Surgery. World Congress of Pediatric Cardiology and Cardiac Surgery. 2. Salvin, J. et al. (2023) Use of a Risk Analytic Algorithm to Inform Weaning from Vasoactive Medication in Patients Following Pediatric Cardiac Surgery. World Congress of Pediatric Cardiology and Cardiac Surgery.

About Etiometry

Founded in 2010, Etiometry is the leader in clinical decision-support software designed to help clinicians in the intensive care setting make data-based decisions regarding their patients’ care and treatment. The company’s technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patients’ conditions to avoid complications and speed recovery. Etiometry has nine FDA clearances and four Health Canada approvals and CE markings. Etiometry is utilized by some of the world’s top academic medical centers as well as leading children’s hospitals ranked by US News and World Report and Newsweek. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering the cost of care through the more effective use of data. To learn more, visit www.etiometry.com.

The Etiometry Platform is an end-to-end data management software solution for the collection, analysis, visualization, and archiving of ICU clinical data. It is designed to facilitate the use of all available data to support the anticipation and management of the dynamic condition of patients requiring intensive care. To learn more, visit www.etiometry.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241003936011/en/